Betaville Intelligence

UNCOOKED ALERT: Clinigen said to ...

Thursday, 4 June 2020, 3:57 pm

Clinigen, an Aim-listed medical supplies company, has come under the spotlight amid takeover talk.

People following the situation said a potential acquirer is eyeing the company, which supplies drugs for clinical trials and also distributes unlicensed pharmaceuticals to pharmacists.

One person following the situation suggested purchaser could be a private equity firm.

Clinigen has grown through a series of acquisitions since it listed on the Aim market in 2012 at 164p...


Register for free to see rest of this article and all public articles from Betaville

Login / Register
Tags: Clinigen

[Disclaimer - the information on Betaville does not consitute any form of investment recommendation and is not intended to be relied upon by readers in making, or refraining from, any investment decisions].

Login to join the conversation